120747-85-5

Basic information

• Product Name: 5-Pyrimidinemethanol, 2-amino- (9CI)
• Synonyms: 5-Pyrimidinemethanol, 2-amino- (9CI);2-Amino-5-pyrimidinemethanol;(2-AMino-pyriMidin-5-yl)-Methanol;2-AMINO-55PYRIMIDINEMETHANOL
• CAS NO: 120747-85-5
• Molecular Formula: C5H7N3O
• Molecular Weight: 125.12858
• Product Categories: PYRIMIDINE;AMINEPRIMARY
• Mol File: 120747-85-5.mol

Chemical Properties

• Boiling Point: 396.3°Cat760mmHg
• Flash Point: 193.5°C
• Appearance: /
• Density: 1.36g/cm³
• Vapor Pressure: 5.43E-07mmHg at 25°C
• Refractive Index: 1.639
• Storage Temp.: 2-8°C(protect from light)
• PKA: 13.36±0.10(Predicted)
• CAS DataBase Reference: 5-Pyrimidinemethanol, 2-amino- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Pyrimidinemethanol, 2-amino- (9CI)(120747-85-5)
• EPA Substance Registry System: 5-Pyrimidinemethanol, 2-amino- (9CI)(120747-85-5)

Safety Data

• Hazardous Substances Data: 120747-85-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
5-Pyrimidinemethanol, 2-amino(9CI) is used as a key intermediate in the synthesis of various pharmaceuticals. Its presence of an amino group allows for further modification and functionalization, enabling the production of a wide range of compounds with diverse biological activities. This makes it a valuable building block in the development of new drugs with potential therapeutic applications.
Used in Agricultural Industry:
5-Pyrimidinemethanol, 2-amino(9CI) is also used as a precursor in the synthesis of agrochemicals. Its potential applications in this industry include the development of new crop protection products, such as pesticides and herbicides, that can help improve crop yield and protect against various pests and diseases. The versatility of its structure allows for the creation of novel compounds with enhanced efficacy and selectivity in agricultural applications.

InChI:InChI=1/C5H7N3O/c6-5-7-1-4(3-9)2-8-5/h1-2,9H,3H2,(H2,6,7,8)

Upstream product

• 120747-84-4 2-aminopyrimidine-5-carboxyaldehyde 

Downstream Products

• 769083-57-0 C₅H₆ClN₃ 
• 120747-86-6 C₅H₆ClN₃*ClH 
• 1046816-75-4 2-chloro-5-hydroxymethyl-pyrimidine 

Relevant articles and documents

cGAS ANTAGONIST COMPOUNDS

Disclosed are novel compounds of Formula (I) that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.

NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF VANIN-1 ENZYME

Compounds, pharmaceutically acceptable salts thereof, are disclosed wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

ANTI-VIRAL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE

Disclosed are compounds and compositions of Formula (I), pharmaceutically acceptable salts and solvates thereof, and their preparation and uses for treating viral infections mediated at least in part by a virus in the Flaviviridae family of viruses.

Pyrazolotriazines as kinase inhibitors

In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]triazine compounds as inhibitors of kinases such as, for example, cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing

PYRAZOLOPYRIMIDINES AS CYCLIN-DEPENDENT KINASE INHIBITORS

In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.

INDOLE DERIVATIVES USEFUL AS HISTAMINE H3 ANTAGONISTS

Disclosed are novel compounds of the formula I wherein M1 is CH or N and M2 is C(R3) or N; R1 is optionally substituted indolyl or an aza derivative thereof; R2 is optionally substituted aryl or heteroaryl; and the remaining variables are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds of formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of formula I in combination with a H1 receptor antagonist.